Difficult days for big pharma
The pharmaceutical industry, it seems, is under almost constant attack at the moment. If it is not Novartis being criticised for its current legal action over India's patent laws, it is the Thai government threatening compulsory licensing on a great…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.